Agios Pharmaceuticals, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States · Nasdaq: AGIO
Agios Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2007. Its shares trade on Nasdaq under the ticker AGIO. It has reported private securities offerings to the US SEC, most recently $78 million sold in a notice filed in 2011.
Agios Pharmaceuticals at a glance
What does Agios Pharmaceuticals do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $78 million sold (2011).
Frequently asked questions about Agios Pharmaceuticals
Where is Agios Pharmaceuticals headquartered?
Agios Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Agios Pharmaceuticals do?
Agios Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Agios Pharmaceuticals a public company?
Yes. Agios Pharmaceuticals, Inc. trades on Nasdaq under the ticker AGIO.
When was Agios Pharmaceuticals founded?
The earliest incorporation on record for Agios Pharmaceuticals, Inc. is in 2007, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.